Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 333

1.

The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis.

Tam S, Fu S, Xu L, Krause KJ, Lairson DR, Miao H, Sturgis EM, Dahlstrom KR.

Oral Oncol. 2018 Jul;82:91-99. doi: 10.1016/j.oraloncology.2018.04.005. Epub 2018 May 21. Review.

PMID:
29909908
2.

MicroRNA-related genetic variants associated with overall survival of head and neck squamous cell carcinoma.

Wilkins OM, Titus AJ, Salas LA, Gui J, Eliot M, Butler RA, Sturgis EM, Li G, Kelsey KT, Christensen BC.

Cancer Epidemiol Biomarkers Prev. 2018 Jun 7. pii: cebp.0002.2018. doi: 10.1158/1055-9965.EPI-18-0002. [Epub ahead of print]

PMID:
29880533
3.

Racial differences in the relationship between tobacco, alcohol, and the risk of head and neck cancer: pooled analysis of US studies in the INHANCE Consortium.

Voltzke KJ, Lee YA, Zhang ZF, Zevallos JP, Yu GP, Winn DM, Vaughan TL, Sturgis EM, Smith E, Schwartz SM, Schantz S, Muscat J, Morgenstern H, McClean M, Li G, Lazarus P, Kelsey K, Gillison M, Chen C, Boffetta P, Hashibe M, Olshan AF.

Cancer Causes Control. 2018 May 14. doi: 10.1007/s10552-018-1026-z. [Epub ahead of print]

PMID:
29761303
4.

Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation.

Frank SJ, Blanchard P, Lee JJ, Sturgis EM, Kies MS, Machtay M, Vikram B, Garden AS, Rosenthal DI, Gunn GB, Fuller CD, Hutcheson K, Lai S, Busse PM, Lee NY, Lin A, Foote RL.

Semin Radiat Oncol. 2018 Apr;28(2):108-113. doi: 10.1016/j.semradonc.2017.12.002. Review.

PMID:
29735186
5.

Response to ASTRO consensus guideline for oropharyngeal cancer: In Regard to Walker et al.

Sher DJ, Adelstein DJ, Bajaj GK, Brizel DM, Cohen EE, Halthore A, Harrison LB, Lu C, Moeller BJ, Quon H, Rocco JW, Sturgis EM, Tishler RB, Trotti A, Waldron J, Eisbruch A.

Pract Radiat Oncol. 2018 May - Jun;8(3):e185-e186. doi: 10.1016/j.prro.2017.08.002. Epub 2017 Aug 5. No abstract available.

PMID:
29724403
6.

A TGF-β1 genetic variant at the miRNA187 binding site significantly modifies risk of HPV16-associated oropharyngeal cancer.

Tao Y, Sturgis EM, Huang Z, Sun Y, Dahlstrom KR, Wei Q, Li G.

Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31530. [Epub ahead of print]

PMID:
29663347
7.

Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer.

Jensen GL, Blanchard P, Gunn GB, Garden AS, David Fuller C, Sturgis EM, Gillison ML, Phan J, Morrison WH, Rosenthal DI, Frank SJ.

Clin Transl Radiat Oncol. 2017 Nov 6;7:28-35. doi: 10.1016/j.ctro.2017.09.008. eCollection 2017 Dec.

8.

Associations between expression levels of nucleotide excision repair proteins in lymphoblastoid cells and risk of squamous cell carcinoma of the head and neck.

Han P, Liu H, Shi Q, Liu Z, Troy JD, Lee WT, Zevallos JP, Li G, Sturgis EM, Wei Q.

Mol Carcinog. 2018 Jun;57(6):784-793. doi: 10.1002/mc.22801. Epub 2018 Mar 25.

PMID:
29528139
9.

TGFβ1 Genetic Variants Predict Clinical Outcomes of HPV-Positive Oropharyngeal Cancer Patients after Definitive Radiotherapy.

Tao Y, Sturgis EM, Huang Z, Wang Y, Wei P, Wang JR, Wei Q, Li G.

Clin Cancer Res. 2018 May 1;24(9):2225-2233. doi: 10.1158/1078-0432.CCR-17-1904. Epub 2018 Feb 20.

PMID:
29463556
10.

Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapy.

Kamal M, Mohamed ASR, Fuller CD, Sturgis EM, Johnson FM, Morrison WH, Gunn GB, Hutcheson KA, Phan J, Volpe S, Ng SP, Ferrarotto R, Frank SJ, Skinner HD, Rosenthal DI, Garden AS.

Cancer. 2018 Apr 1;124(7):1415-1427. doi: 10.1002/cncr.31235. Epub 2018 Jan 16.

PMID:
29338089
11.

HPV vaccination in boys should not be discounted.

Tam S, Sturgis EM.

Lancet Public Health. 2016 Nov;1(1):e2-e3. doi: 10.1016/S2468-2667(16)30003-2. Epub 2016 Sep 27. No abstract available.

12.

Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors.

MD Anderson Head and Neck Cancer Symptom Working Group, Kamal M, Rosenthal DI, Volpe S, Goepfert RP, Garden AS, Hutcheson KA, Al Feghali KA, Meheissen MAM, Eraj SA, Dursteler AE, Williams B, Smith JB, Aymard JM, Berends J, White AL, Frank SJ, Morrison WH, Cardoso R, Chambers MS, Sturgis EM, Mendoza TR, Lu C, Mohamed ASR, Fuller CD, Gunn GB.

Radiother Oncol. 2018 Jan;126(1):75-80. doi: 10.1016/j.radonc.2017.10.037. Epub 2017 Dec 8.

PMID:
29229507
13.

Malignant perivascular epithelioid cell tumor of the oropharynx with strong TFE3 expression mimicking alveolar soft part sarcoma: a case report and review of the literature.

Saluja K, Thomas J, Zhang S, Sturgis EM, Jain KS, Prieto VG, El-Naggar AK, Bell D.

Hum Pathol. 2018 Jun;76:149-155. doi: 10.1016/j.humpath.2017.11.016. Epub 2017 Dec 5.

PMID:
29208563
14.

Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer.

Amit M, Tam S, Boonsripitayanon M, Cabanillas ME, Busaidy NL, Grubbs EG, Lai SY, Gross ND, Sturgis EM, Zafereo ME.

JAMA Otolaryngol Head Neck Surg. 2018 Feb 1;144(2):108-114. doi: 10.1001/jamaoto.2017.2416.

PMID:
29192312
15.

Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old.

MD Anderson Head and Neck Cancer Symptom Working Group, Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymard JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Brandon Gunn G.

Radiat Oncol. 2017 Nov 23;12(1):186. doi: 10.1186/s13014-017-0921-x.

16.

Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer.

Economides MP, Amit M, Mahale PS, Hosry JJ, Jiang Y, Bharadwaj U, Sturgis EM, Torres HA.

Cancer. 2018 Mar 1;124(5):960-965. doi: 10.1002/cncr.31146. Epub 2017 Nov 17.

PMID:
29149493
17.

Adjuvant External Beam Radiotherapy in Locally Advanced Differentiated Thyroid Cancer.

Tam S, Amit M, Boonsripitayanon M, Cabanillas ME, Busaidy NL, Gunn GB, Lai SY, Gross ND, Sturgis EM, Zafereo ME.

JAMA Otolaryngol Head Neck Surg. 2017 Dec 1;143(12):1244-1251. doi: 10.1001/jamaoto.2017.2077. No abstract available.

PMID:
29098272
18.

Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx.

Lu Z, Sturgis EM, Zhu L, Zhang H, Tao Y, Wei P, Wei Q, Li G.

Mol Carcinog. 2018 Mar;57(3):361-369. doi: 10.1002/mc.22760. Epub 2017 Nov 13.

PMID:
29073727
19.

Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer.

Pena I, Clayman GL, Grubbs EG, Bergeron JM Jr, Waguespack SG, Cabanillas ME, Dadu R, Hu MI, Fellman BM, Li Y, Gross ND, Lai SY, Sturgis EM, Zafereo ME.

Head Neck. 2018 Jan;40(1):79-85. doi: 10.1002/hed.24969. Epub 2017 Oct 16.

PMID:
29044788
20.

Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.

Dahlstrom KR, Anderson KS, Field MS, Chowell D, Ning J, Li N, Wei Q, Li G, Sturgis EM.

Cancer. 2017 Dec 15;123(24):4886-4894. doi: 10.1002/cncr.30955. Epub 2017 Sep 12.

PMID:
28898394
21.

Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old.

MD Anderson Head and Neck Cancer Symptom Working Group, Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymard JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Gunn GB.

Radiat Oncol. 2017 Sep 9;12(1):150. doi: 10.1186/s13014-017-0878-9. Erratum in: Radiat Oncol. 2017 Nov 23;12 (1):186.

22.

Medical Care Cost of Oropharyngeal Cancer among Texas Patients.

Lairson DR, Wu CF, Chan W, Dahlstrom KR, Tam S, Sturgis EM.

Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1443-1449. doi: 10.1158/1055-9965.EPI-17-0220. Epub 2017 Aug 24.

PMID:
28838945
23.

Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis.

Pollard C 3rd, Nguyen TP, Ng SP, Frank SJ, Garden AS, Gunn GB, Fuller CD, Beadle BM, Morrison WH, Shah SJ, Wang H, Tung S, Wang C, Ginsberg LD, Zafereo ME, Sturgis EM, Su SY, Hanna EY, Rosenthal DI, Phan J.

Head Neck. 2017 Oct;39(10):2079-2087. doi: 10.1002/hed.24872. Epub 2017 Jul 25.

PMID:
28741749
24.

Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.

Chandrasekharappa SC, Chinn SB, Donovan FX, Chowdhury NI, Kamat A, Adeyemo AA, Thomas JW, Vemulapalli M, Hussey CS, Reid HH, Mullikin JC, Wei Q, Sturgis EM.

Cancer. 2017 Oct 15;123(20):3943-3954. doi: 10.1002/cncr.30802. Epub 2017 Jul 5.

25.

Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.

Zhu L, Sturgis EM, Zhang H, Lu Z, Tao Y, Wei Q, Li G.

Int J Cancer. 2017 Oct 1;141(7):1355-1364. doi: 10.1002/ijc.30849. Epub 2017 Jul 7.

PMID:
28646528
26.

Genome-scale identification of microRNA-related SNPs associated with risk of head and neck squamous cell carcinoma.

Wilkins OM, Titus AJ, Gui J, Eliot M, Butler RA, Sturgis EM, Li G, Kelsey KT, Christensen BC.

Carcinogenesis. 2017 Oct 1;38(10):986-993. doi: 10.1093/carcin/bgx056.

27.

Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline.

Sher DJ, Adelstein DJ, Bajaj GK, Brizel DM, Cohen EEW, Halthore A, Harrison LB, Lu C, Moeller BJ, Quon H, Rocco JW, Sturgis EM, Tishler RB, Trotti A, Waldron J, Eisbruch A.

Pract Radiat Oncol. 2017 Jul - Aug;7(4):246-253. doi: 10.1016/j.prro.2017.02.002. Epub 2017 Apr 17.

PMID:
28428019
28.

Reduced mRNA expression of nucleotide excision repair genes in lymphocytes and risk of squamous cell carcinoma of the head and neck.

Han P, Gao F, Liu H, Liu Z, Shi Q, Troy JD, Owzar K, Lee W, Zevallos JP, Sturgis EM, Wei Q.

Carcinogenesis. 2017 May 1;38(5):504-510. doi: 10.1093/carcin/bgx028.

29.

Is there an increased risk of cancer among spouses of patients with an HPV-related cancer: A systematic review.

Mirghani H, Sturgis EM, Aupérin A, Monsonego J, Blanchard P.

Oral Oncol. 2017 Apr;67:138-145. doi: 10.1016/j.oraloncology.2017.02.024. Epub 2017 Feb 28. Review.

PMID:
28351568
30.

Association between miRNA-binding site polymorphisms in double-strand break repair genes and risk of recurrence in patients with squamous cell carcinomas of the non-oropharynx.

Zhu L, Sturgis EM, Lu Z, Zhang H, Wei P, Wei Q, Li G.

Carcinogenesis. 2017 Apr 1;38(4):432-438. doi: 10.1093/carcin/bgx019.

PMID:
28334093
31.

HPV16 DNA and integration in normal and malignant epithelium: implications for the etiology of laryngeal squamous cell carcinoma.

Chen X, Gao L, Sturgis EM, Liang Z, Zhu Y, Xia X, Zhu X, Chen X, Li G, Gao Z.

Ann Oncol. 2017 May 1;28(5):1105-1110. doi: 10.1093/annonc/mdx027.

32.

Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysis.

Wong ATT, Lai SY, Gunn GB, Beadle BM, Fuller CD, Barrow MP, Hofstede TM, Chambers MS, Sturgis EM, Mohamed ASR, Lewin JS, Hutcheson KA.

Oral Oncol. 2017 Mar;66:75-80. doi: 10.1016/j.oraloncology.2017.01.006. Epub 2017 Jan 21.

33.

A genome-wide association study yields five novel thyroid cancer risk loci.

Gudmundsson J, Thorleifsson G, Sigurdsson JK, Stefansdottir L, Jonasson JG, Gudjonsson SA, Gudbjartsson DF, Masson G, Johannsdottir H, Halldorsson GH, Stacey SN, Helgason H, Sulem P, Senter L, He H, Liyanarachchi S, Ringel MD, Aguillo E, Panadero A, Prats E, Garcia-Castaño A, De Juan A, Rivera F, Xu L, Kiemeney LA, Eyjolfsson GI, Sigurdardottir O, Olafsson I, Kristvinsson H, Netea-Maier RT, Jonsson T, Mayordomo JI, Plantinga TS, Hjartarson H, Hrafnkelsson J, Sturgis EM, Thorsteinsdottir U, Rafnar T, de la Chapelle A, Stefansson K.

Nat Commun. 2017 Feb 14;8:14517. doi: 10.1038/ncomms14517.

34.

Prevalence of and Risk Factors for Oral Human Papillomavirus Infection With Multiple Genotypes in the United States.

Bui TC, Tran LT, Thai TN, Shete SS, Vidrine DJ, Sturgis EM.

Sex Transm Dis. 2017 Mar;44(3):166-172. doi: 10.1097/OLQ.0000000000000563.

PMID:
28178115
35.

Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx.

Zhang Y, Sturgis EM, Li Y, Wei Q, Huang Z, Li G.

Sci Rep. 2017 Jan 3;7:39765. doi: 10.1038/srep39765.

36.

Apoptotic capacity and risk of squamous cell carcinoma of the head and neck.

Liu Z, Liu H, Han P, Gao F, Dahlstrom KR, Li G, Owzar K, Zevallos JP, Sturgis EM, Wei Q.

Eur J Cancer. 2017 Feb;72:166-176. doi: 10.1016/j.ejca.2016.11.018. Epub 2016 Dec 26.

37.

Human Papillomavirus-Associated Oropharyngeal Cancer: Not Just White Men Anymore.

Dahlstrom KR, Anderson KS, Sturgis EM.

JAMA Oncol. 2016 Dec 8. doi: 10.1001/jamaoncol.2016.3510. [Epub ahead of print] No abstract available.

PMID:
27930755
38.

E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx.

Li Y, Sturgis EM, Zhu L, Cao X, Wei Q, Zhang H, Li G.

Mol Carcinog. 2017 Apr;56(4):1335-1343. doi: 10.1002/mc.22595. Epub 2017 Jan 2.

PMID:
27864908
39.

The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.

Liederbach E, Kyrillos A, Wang CH, Liu JC, Sturgis EM, Bhayani MK.

Int J Cancer. 2017 Feb 1;140(3):504-512. doi: 10.1002/ijc.30442. Epub 2016 Nov 3.

40.

A functional variant at the miRNA binding site in E2F1 gene is associated with risk and tumor HPV16 status of oropharynx squamous cell carcinoma.

Yuan Y, Sturgis EM, Zhu L, Lu M, Li Y, Wei Q, Li G.

Mol Carcinog. 2017 Mar;56(3):1100-1106. doi: 10.1002/mc.22576. Epub 2016 Oct 20.

PMID:
27677255
41.

Reply to radiotherapy for human papillomavirus-positive oropharyngeal cancers in the National Cancer Data Base.

Garden AS, Fuller CD, Rosenthal DI, William WN Jr, Gunn GB, Beadle BM, Johnson FM, Morrison WH, Phan J, Frank SJ, Kies MS, Sturgis EM.

Cancer. 2016 Nov 15;122(21):3411-3412. doi: 10.1002/cncr.30193. Epub 2016 Jul 15. No abstract available.

42.

Effect of human papillomavirus seropositivity and E2F2 promoter variants on risk of squamous cell carcinomas of oropharynx and oral cavity.

Li Y, Sturgis EM, Yuan Y, Lu M, Cao X, Wei Q, Li G.

Carcinogenesis. 2016 Sep 8. pii: bgw095. [Epub ahead of print]

43.

Feeding Tube Utilization in Patients with Salivary Gland Malignancies.

Chen DW, Lewin JS, Xu L, Lai SY, Gunn GB, Fuller CD, Mohamed AS, Kanwar A, Sturgis EM, Hutcheson KA.

Otolaryngol Head Neck Surg. 2017 Jan;156(1):109-117. doi: 10.1177/0194599816666038. Epub 2016 Oct 3.

44.

Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234).

Divi V, Harris J, Harari PM, Cooper JS, McHugh J, Bell D, Sturgis EM, Cmelak AJ, Suntharalingam M, Raben D, Kim H, Spencer SA, Laramore GE, Trotti A, Foote RL, Schultz C, Thorstad WL, Zhang QE, Le QT, Holsinger FC.

Cancer. 2016 Jul 15. doi: 10.1002/cncr.30204. [Epub ahead of print]

45.

Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.

Blanchard P, Garden AS, Gunn GB, Rosenthal DI, Morrison WH, Hernandez M, Crutison J, Lee JJ, Ye R, Fuller CD, Mohamed AS, Hutcheson KA, Holliday EB, Thaker NG, Sturgis EM, Kies MS, Zhu XR, Mohan R, Frank SJ.

Radiother Oncol. 2016 Jul;120(1):48-55. doi: 10.1016/j.radonc.2016.05.022. Epub 2016 Jun 21.

46.

Osteoradionecrosis in patients with salivary gland malignancies.

Tucker JR, Xu L, Sturgis EM, Mohamed AS, Hofstede TM, Chambers MS, Lai SY, Fuller CD, Beadle B, Gunn GB, Hutcheson KA.

Oral Oncol. 2016 Jun;57:1-5. doi: 10.1016/j.oraloncology.2016.03.006. Epub 2016 Mar 31.

47.

Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.

Sigurdson AJ, Brenner AV, Roach JA, Goudeva L, Müller JA, Nerlich K, Reiners C, Schwab R, Pfeiffer L, Waldenberger M, Braganza M, Xu L, Sturgis EM, Yeager M, Chanock SJ, Pfeiffer RM, Abend M, Port M.

Carcinogenesis. 2016 Jul;37(7):677-684. doi: 10.1093/carcin/bgw047. Epub 2016 Apr 28.

48.

Expanding the benefits of HPV vaccination to boys and men.

Schmeler KM, Sturgis EM.

Lancet. 2016 Apr 30;387(10030):1798-9. doi: 10.1016/S0140-6736(16)30314-2. Epub 2016 Apr 28. No abstract available.

PMID:
27203488
49.

Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy.

Chen X, Sturgis EM, Wang C, Cao X, Li Y, Wei Q, Li G.

Oncotarget. 2016 Jun 7;7(23):35015-25. doi: 10.18632/oncotarget.9014.

50.

Concordance of oral HPV prevalence between patients with oropharyngeal cancer and their partners.

Tsao AS, Papadimitrakopoulou V, Lin H, Guo M, Lee JJ, Holsinger FC, Hong WK, Sturgis EM.

Infect Agent Cancer. 2016 Apr 27;11:21. doi: 10.1186/s13027-016-0066-9. eCollection 2016.

Supplemental Content

Loading ...
Support Center